Hestia was launched in 2019 as a Shared Service Center for the Cardiovascular Sector with a focus
on thrombosis services and thus as a partner of Thrombosis Services in the Netherlands and abroad. Hestia
originated from several companies which now, as one company, provides a unique service offering
thrombosis software (TiS), measuring equipment (POCT), virtual medical services, procurement (efficient and
economical purchase of medical devices) and 24x7 skilled (medical) services.
Many developments are taking
place in the Dutch healthcare sector and beyond, such as living at home for longer, increasing independence,
limiting loneliness, stimulating self-care, making homes more future-proof, shortening rehabilitation times and
improving the client experience. Many Dutch people are now or will be affected by 1 one of the "Big 6"
diseases. Heart and Vascular is one of those conditions for which many citizens receive care. Care for the
monitoring and treatment of atrial fibrillation and anticoagulation, for example. Anticoagulation care in the
Netherlands is provided by anticoagulation clinics that operate from a Primary Care Diagnostic Centre (EDC), a
hospital, or from an independent entity. The current anticoagulation services offer scope for innovation. The
macro-economic developments also apply to this market. The client becomes more self-reliant and needs to be
given (and take) more control and expects a better experience as a result of which the process and service should
be better aligned to the needs of the client, but also the professional and healthcare staff to manage the
workload. In short, the client expects innovation. There is also room for innovation along the axis of medication
safety. The opportunities that digitization brings can offer the desired innovation for this market, clients,
and professionals. With our Shared Service concept for the thrombosis service, Hestia's ambition is to put
the customer experience first with its range of services, to increase process efficiency, promote quality, prevent
errors, and reduce costs. We do this as a partner of anticoagulation clinics.
Anticoagulation clinics are
becoming more aware of the need for change. For example, the policy of health insurers who want more regional
collaboration, want to encourage self-care (self-measurement) and want to reduce costs while maintaining quality
is changing.
Insurers will adjust their contracting requirements accordingly. This poses challenges for
some anticoagulation clinic providers that we want to address together with our partners, and beyond that, we also want to further
develop our services in co-creation.
The introduction of oral anticoagulation, the need for better monitoring
of atrial fibrillation, the emergence of a greater role for district nurses and GPs, and the possibilities of
improving remote care, diagnostics, and measurements through effective software, a new form of remote medical care, and an effective
procurement solution are reasons for us to actively develop this market in co-creation with partners.
